Teva Pharmaceutical Industries Limited Sponsored ADR Forecast, price target & analysts
Teva Pharmaceutical Industries Limited Sponsored ADR Target price 2025 - Analyst rating & recommendation
Teva Pharmaceutical Industries Limited Sponsored ADR Classifications & Recommendation:
Teva Pharmaceutical Industries Limited Sponsored ADR Price Target
| Target Price | $0.06 |
| Price | $26.32 |
| Deviation |
99.79%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Teva Pharmaceutical Industries Limited Sponsored ADR 2026 .
The average Teva Pharmaceutical Industries Limited Sponsored ADR target price is $0.06.
This is
99.79%
register free of charge
$0.06
99.78%
register free of charge
$0.06
99.79%
register free of charge
|
|
| A rating was issued by 9 analysts: 0 Analysts recommend Teva Pharmaceutical Industries Limited Sponsored ADR to buy, 3 to hold and 6 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Teva Pharmaceutical Industries Limited Sponsored ADR stock has an average upside potential 2026 of
99.79%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 16.54 | 17.22 |
| 4.40% | 4.11% | |
| EBITDA Margin | 28.09% | 29.04% |
| 5.16% | 3.39% | |
| Net Margin | -9.91% | 17.49% |
| 180.83% | 276.54% |
7 Analysts have issued a sales forecast Teva Pharmaceutical Industries Limited Sponsored ADR 2025 . The average Teva Pharmaceutical Industries Limited Sponsored ADR sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Teva Pharmaceutical Industries Limited Sponsored ADR EBITDA forecast 2025. The average Teva Pharmaceutical Industries Limited Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Teva Pharmaceutical Industries Limited Sponsored ADR Analysts have issued a net profit forecast 2025. The average Teva Pharmaceutical Industries Limited Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.45 | 2.63 |
| 190.00% | 281.38% | |
| P/E | 10.02 | |
| EV/Sales | 2.63 |
6 Analysts have issued a Teva Pharmaceutical Industries Limited Sponsored ADR forecast for earnings per share. The average Teva Pharmaceutical Industries Limited Sponsored ADR EPS is
This results in the following potential growth metrics and future valuations:
Teva Pharmaceutical Industries Limited Sponsored ADR...
Current Teva Pharmaceutical Industries Limited Sponsored ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 03 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Sep 24 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Jun 26 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Jun 06 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | May 28 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 03 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Sep 24 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Jun 26 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Jun 06 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 28 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
